GE HealthCare raises dividend to USD 0.04 per GE HealthCare stock

Published on 10/05/2026 at 12:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The quarterly payout reaches USD 0.04 per share. GE HealthCare stock costs EUR 57.03 on October 5, 2026 after EUR 57.28.

Bauhaus-Grafikposter mit Primärfarben, geometrischen Formen und zentralem MEDTECH-Text — GE HealthCare US36266G1076 als Bauhaus Poster mit geometrischen Primärfarben-Formen und zentralem MEDTECH Schriftzug, Illustration mit AI erstellt.

GE HealthCare (ISIN US36266G1076) was trading at EUR 57.03 at Lang & Schwarz on October 5, 2026 at 12:29 p.m. CEST, down 0.44 percent versus the prior close of EUR 57.28. On September 22, 2026, the company declared a quarterly dividend of USD 0.04 per share, according to GE HealthCare.

Dividend reaches USD 0.04

The new payout applies to the third quarter of 2026 and is payable on November 13, 2026, to shareholders of record on October 23, 2026. Compared with the previous quarterly payment of USD 0.035, the increase is 14.29 percent.

The dividend is the most recent capital-allocation signal in the company calendar. Its cash value remains small relative to earnings, but the increase matters because it was declared while the business is managing pressure in Patient Care Solutions.

Second-quarter revenue rises

For the second quarter of 2026, GE HealthCare reported revenue of USD 5.295 billion, up 5.70 percent from the year-earlier period, according to StockTitan. Organic revenue growth was 3.50 percent, while organic orders increased 11.10 percent and the backlog reached USD 23.9 billion.

Diluted earnings per share came to USD 1.24, while adjusted earnings per share were USD 1.13. Patient Care Solutions revenue fell 13.30 percent to USD 675 million, contrasting with 7.90 percent growth in Advanced Imaging Solutions and 15.60 percent growth in Pharmaceutical Diagnostics.

Guidance keeps the margin test

Management reaffirmed 2026 organic revenue growth guidance of 3.00 percent to 4.00 percent and adjusted earnings per share guidance of USD 4.80 to USD 5.00. Adjusted EBIT margin guidance stands at 15.40 percent to 15.70 percent, while the company expects free cash flow of USD 1.6 billion.

For market context, GE HealthCare stock was quoted at USD 64.29 on Nasdaq at the October 2, 2026 close. The same dated market snapshot showed a USD 58.75 to USD 89.77 52-week range and a USD 29.0 billion market capitalization, while the consensus price target was USD 78.39 across 22 analysts, according to MarketBeat.

GE HealthCare stock stays in focus

The contrast is clear: orders and backlog are expanding faster than reported revenue, but the Patient Care Solutions decline and the 15.40 percent to 15.70 percent adjusted EBIT margin target remain central measures for the next report.

GE HealthCare was trading at EUR 57.03 at Lang & Schwarz on October 5, 2026 at 12:29 p.m. CEST, down 0.44 percent versus the prior close of EUR 57.28. The further course of trading is shown by the continuously updated real-time quote of GE HealthCare stock.